Form 8-K - Current report:
SEC Accession No. 0001104659-22-028128
Filing Date
2022-02-28
Accepted
2022-02-28 16:34:32
Documents
13
Period of Report
2022-02-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm227815d1_8k.htm   iXBRL 8-K 26150
2 EXHIBIT 10.1 tm227815d1_ex10-1.htm EX-10.1 38635
  Complete submission text file 0001104659-22-028128.txt   247594

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA anip-20220223.xsd EX-101.SCH 3063
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE anip-20220223_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE anip-20220223_pre.xml EX-101.PRE 22615
7 EXTRACTED XBRL INSTANCE DOCUMENT tm227815d1_8k_htm.xml XML 3464
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31812 | Film No.: 22690321
SIC: 2834 Pharmaceutical Preparations